USD/JPY rises to 6-month high

After a rocky Wednesday, financial markets stabilised on Thursday as trade war fears eased. Asian moved back up with the Nikkei rising 1.17%, while Chinese equities rebounded strongly with the Shanghai and Shenzhen Composites rising 2.17% and 2.73% respectively. Similarly, European stocks opened slightly higher with the Eurostoxx 50 up 0.09% and the German DAX rising 0.27%.

In the FX market, the greenback enjoyed a nice recovery as investors fled risky assets. The dollar index surged to 94.78 (its high level since July 3rd) but consolidated gains on Thursday morning. Surprisingly, the Japanese yen, which usually appreciates during period of rising risk aversion, fell substantially over the last 24 hours. USD/JPY rose more 1.30% to 112.42, its highest level since January 10th. The currency pair is currently testing a key resistance level, which corresponds to the top of its multi-month downtrend channel.


Stay on top of the markets with Swissquote’s News & Analysis


It is still why the market has punished the yen against the backdrop of deteriorating risk environment. However, the surge in demand for upside protection in USD/JPY suggests that investors are getting anxious about further yen weakness. Indeed, call prices for all maturity increased with the 1-week 25-delta risk reversal measure climbing to -0.34% from -1.28% two weeks ago.

Today, traders will focus on the publication of the June inflation report in the US. Headline inflation is expected to have risen 2.9%y/y in June, while the core gauge, which excludes the most volatile components such as energy and food prices, should come in at 2.3%y/y. A stronger print in core inflation should provide the last nudge needed for USD/JPY to break the resistance as it would support the case for more rate hike this year.

This report has been prepared by AC Markets and is solely been published for informational purposes and is not to be construed as a solicitation or an offer to buy or sell any currency or any other financial instrument. Views expressed in this report may be subject to change without prior notice and may differ or be contrary to opinions expressed by AC Markets personnel at any given time. ACM is under no obligation to update or keep current the information herein, the report should not be regarded by recipients as a substitute for the exercise of their own judgment.